OMEGAQUANT ANALYTICS, LLC

Medtech · Private

blood test measuring erythrocyte omega-3 fatty acid levels as an early biomarker for Alzheimer's disease risk

Grants
$834K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$79K
2 awards · Defense
#540 of 4531 in medtech
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Developing a blood fatty acid-based algorithm as an early predictor of insulin resistance: Applying machine learning to harmonized data from prospective cohort studies$327,420
Federal grantDepartment of Health and Human Services · Phase I · Developing a blood fatty acid-based algorithm as an early predictor of cognitive decline and dementia: Applying machine learning to harmonized data from prospective cohort studies$506,500
Federal contractDepartment of Defense · Dbs Sample Cards For Vitamin D Collection And Analysis.$48,180
Federal contractDepartment of Defense · S2P2 : OMEGA-3 Lab Kit : Solicitation W911S225U1758$31,185
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
537ALLELE DIAGNOSTICS INC$84K—
538Caption Health$81K$69M
539Cleerly, Inc.$80K$266M
540OMEGAQUANT ANALYTICS, LLC$79K—
541ADM TRONICS UNLIMITED, INC.$78K$300K
542STEXOLE LLC$77K—
543Objective Biotechnology, Inc.$75K$715K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Method For Measuring And Managing Red Blood Cell OMEGA-3 Fatty Acid Docosahexaenoic Acid Level In Human Females To Support A Term Pregnancy And Reduce Risk Of Spontaneous Preterm Birthapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.